Chemo-RaST with bortezomib inhibits multiple myeloma relapse.
Saved in:
| Title: | Chemo-RaST with bortezomib inhibits multiple myeloma relapse. |
|---|---|
| Authors: | Ghai A; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA., Zheleznyak A; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA., Egbulefu C; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA., Blasi N; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA., Black K; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA., Tang R; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA., Cooper ML; Department of Medicine, Washington University School of Medicine, Missouri, USA., Vij K; Department of Medicine, Washington University School of Medicine, Missouri, USA.; Department of Pathology and Immunology, Washington University School of Medicine, Missouri, USA., Vij R; Department of Medicine, Washington University School of Medicine, Missouri, USA., DiPersio J; Department of Medicine, Washington University School of Medicine, Missouri, USA., Shokeen M; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Medicine, Washington University School of Medicine, Missouri, USA.; Department of Biomedical Engineering, Washington University in St. Louis, Missouri, USA., Achilefu S; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA.; Department of Medicine, Washington University School of Medicine, Missouri, USA.; Department of Biomedical Engineering, Washington University in St. Louis, Missouri, USA.; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Missouri, USA. |
| Source: | Theranostics [Theranostics] 2025 Sep 08; Vol. 15 (18), pp. 9911-9921. Date of Electronic Publication: 2025 Sep 08 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41041064 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Chemo-RaST with bortezomib inhibits multiple myeloma relapse. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ghai+A%22">Ghai A</searchLink>; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Zheleznyak+A%22">Zheleznyak A</searchLink>; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Egbulefu+C%22">Egbulefu C</searchLink>; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Blasi+N%22">Blasi N</searchLink>; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Black+K%22">Black K</searchLink>; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Tang+R%22">Tang R</searchLink>; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+ML%22">Cooper ML</searchLink>; Department of Medicine, Washington University School of Medicine, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Vij+K%22">Vij K</searchLink>; Department of Medicine, Washington University School of Medicine, Missouri, USA.; Department of Pathology and Immunology, Washington University School of Medicine, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Vij+R%22">Vij R</searchLink>; Department of Medicine, Washington University School of Medicine, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22DiPersio+J%22">DiPersio J</searchLink>; Department of Medicine, Washington University School of Medicine, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Shokeen+M%22">Shokeen M</searchLink>; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Medicine, Washington University School of Medicine, Missouri, USA.; Department of Biomedical Engineering, Washington University in St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Achilefu+S%22">Achilefu S</searchLink>; Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Biomedical Engineering, UT Southwestern Medical Center, Dallas, Texas, USA.; Department of Medicine, Washington University School of Medicine, Missouri, USA.; Department of Biomedical Engineering, Washington University in St. Louis, Missouri, USA.; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Missouri, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101552395%22">Theranostics</searchLink> [Theranostics] 2025 Sep 08; Vol. 15 (18), pp. 9911-9921. <i>Date of Electronic Publication: </i>2025 Sep 08 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101552395 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1838-7640 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218387640%22">18387640 </searchLink><i>NLM ISO Abbreviation: </i>Theranostics <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41041064 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7150/thno.111508 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 9911 Titles: – TitleFull: Chemo-RaST with bortezomib inhibits multiple myeloma relapse. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ghai A – PersonEntity: Name: NameFull: Zheleznyak A – PersonEntity: Name: NameFull: Egbulefu C – PersonEntity: Name: NameFull: Blasi N – PersonEntity: Name: NameFull: Black K – PersonEntity: Name: NameFull: Tang R – PersonEntity: Name: NameFull: Cooper ML – PersonEntity: Name: NameFull: Vij K – PersonEntity: Name: NameFull: Vij R – PersonEntity: Name: NameFull: DiPersio J – PersonEntity: Name: NameFull: Shokeen M – PersonEntity: Name: NameFull: Achilefu S IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 09 Text: 2025 Sep 08 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1838-7640 Numbering: – Type: volume Value: 15 – Type: issue Value: 18 Titles: – TitleFull: Theranostics Type: main |
| ResultId | 1 |
